Peer Review History
| Original SubmissionJune 13, 2024 |
|---|
|
Dear Dr. Islam, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Fernanda L. F. Dal Pizzol Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide a complete Data Availability Statement in the submission form, ensuring you include all necessary access information or a reason for why you are unable to make your data freely accessible. If your research concerns only data provided within your submission, please write "All data are in the manuscript and/or supporting information files" as your Data Availability Statement. Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Partly Reviewer #2: Partly ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: Yes Reviewer #2: No ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: No Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: The manuscript effectively highlights the growing burden of dementia in LMICs like Bangladesh and the lack of adequate caregiving support. The introduction clearly establishes the need for scalable interventions such as the WHO iSupport manual. The research questions are well-defined, focusing on improving dementia knowledge and caregiving outcomes, and they are justified within the context of the limited literature on dementia care in Bangladesh. However, while iSupport was originally designed for informal caregivers, the inclusion of formal caregivers in the study is not sufficiently justified, particularly since the content remains unchanged. Formal caregivers might find the examples used in iSupport irrelevant, potentially leading to high attrition or non-adherence, especially given that the eligibility criteria do not require them to be dementia caregivers. Adaptations specific to formal caregivers may be necessary, and as the project is already in progress, the authors should discuss how they plan to address this issue. Study Design and Methodology The study protocol outlines a robust methodology that combines quantitative and qualitative approaches. The use of validated tools such as DKAS, MCSI, and GAD-7 enhances credibility. However, several methodological concerns should be addressed: • The non-randomized sampling method and reliance on purposive sampling may introduce selection bias, potentially limiting generalizability. While the authors acknowledge these as limitations, their impact on the validity of the findings should be discussed more explicitly. • The recruitment of formal caregivers from a single agency may not capture the diversity of caregiving experiences in Bangladesh. Expanding recruitment to multiple agencies or organizations would improve the representativeness of the sample. • The eligibility criterion for formal caregivers—“experienced in providing care to older persons”—is vague. Defining a minimum number of years of caregiving experience would improve clarity and ensure consistency in participant selection. • One of the research questions asks whether the impact of iSupport varies with the level of caregiving skills among formal caregivers. However, the manuscript does not specify how caregiving skill levels will be assessed. A clear operational definition or assessment framework should be provided. Adaptation of iSupport to Bangladesh The authors describe the translation and adaptation of iSupport for the Bangladeshi context, including stakeholder consultations and pre-testing. However, the WHO has developed an Adaptation and Implementation Guide (World Health Organization, 2019), which provides structured recommendations for localization. The authors could consider aligning their adaptation process with this guide to ensure cultural and contextual relevance. Intervention and Digital Accessibility More details are needed regarding how iSupport will be presented online. For example: • Will it be structured as an e-book, a blog, or an interactive learning platform? • How will users navigate different modules and lessons? • Are there any interactive elements, quizzes, or progress-tracking features? Additionally, digital literacy and internet access barriers could impact adherence. A brief discussion on how these challenges will be addressed—such as providing offline materials or digital literacy training—would strengthen the feasibility argument. Statistical Analysis and Data Management The statistical analysis plan is generally sound, but further details are needed on: • How missing data will be handled in the analysis. • The justification for the high attrition rate assumption—providing relevant citations for similar studies would strengthen this estimate. The manuscript also describes strong data security measures, including the use of SurveyCTO and password-protected storage. However, it does not explicitly state whether the data will be made publicly available post-study. Clarifying the data sharing plan would improve research transparency. Qualitative Analysis While the qualitative methods are well-detailed, the manuscript does not specify strategies for ensuring reliability in coding and analysis. Providing details on how themes will be identified, how inter-coder reliability will be maintained, and whether software will be used for analysis would enhance methodological rigor. Discussion and Broader Implications The discussion section primarily focuses on justifying the methodology and acknowledging potential challenges. However, it could be strengthened by: • Expanding on the broader implications of the findings for dementia care policy and practice in Bangladesh. • Addressing how the study results could inform future adaptations of iSupport or similar interventions in other LMICs. Ethical and Financial Disclosure The financial disclosure statement appears contradictory to the acknowledgment section. This should be clarified to ensure consistency. Overall, this is a well-constructed study protocol that addresses a significant gap in dementia care research in Bangladesh. The study's potential impact is notable, but addressing the outlined concerns—particularly regarding formal caregiver inclusion, intervention delivery, data transparency, and methodological details—will further enhance its rigor and relevance. Reviewer #2: This study aims to assess the feasibility of using the WHO iSupport (printed) manual with family and formal carers in Bangladesh. There is no mention how the manual would be used in an "online" program as mentioned in the paper. It is also not clear how the manual would be translated into the local language and culturally adapted. Has permission from the WHO been sought for this adaptation? Possibly the cultural adaptation needs to be tested in a pilot study in a smaller sample of carers and professionals, to see if is understandable and useable, using qualitative methods. The primary aim of the study is to see if iSupport improves the carers knowledge about dementia. While it is clear that the family carers are managing PWD, it is unclear who the formal carers are, and if they are actually managing PWD. It is also not clear why the authors are recruiting a larger sample of formal carers and why they are looking for male vs female differences in the outcome. The two samples could be equal, based on the sample size calculation? There is no mention about the translation and validation of all the study instruments into the local language. No references are provided if this has already been done before the study. It is not clear why the iSupport manual would be available to the carers only for two months. What is the reason for this restriction, if at all, and how would the researchers ensure that the manual is not available after this two month period? Without a control group it may not be possible to study the feasibility or "effectiveness" of using the iSupport to test the secondary aims of improvement in caregiver skills, competency, distress, quality of life, etc. In the consent form there is mention that the formal carers would be monetarily compensated while the family carers would receive no money or incentives. No mention or reason for this is given in the paper itself. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Upasana Baruah Reviewer #2: Yes: Mathew Varghese ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Islam, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Fernanda L. F. Dal Pizzol Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: The revised version of the manuscript represents a substantial improvement and addresses many of the concerns raised in the initial review. The rationale, methodology, and objectives are clearer, and the adaptation process has been more thoroughly described. However, there are still a few issues that require further clarification and revision to enhance the overall clarity, transparency, and rigor of the study. Access to Intervention Materials (pg. 12, lines 228-229) The authors state that “access to, both, online and printed versions will be restricted by disabling online access and taking back the printed manual before their end-line survey.” While the intention is understandable, removing the printed version does not fully guarantee restricted access, as participants could easily photocopy or retain copies of the manual during the intervention period. Unlike the online platform, which is more easily controlled via login access, printed materials cannot be secured in the same way. This should be acknowledged as a limitation of the study in the manuscript. Clarification Needed-Comment 2.2 In response to comment 2.2, the authors state: “To our knowledge, there are 26 fully operational caregiving service providers in Bangladesh, with only three providing similar level of service in Bangladesh.” The meaning of “similar level of service” is unclear. It would be helpful to specify what is meant by this - does it refer to the quality of training, type of clientele, scope of services, or caregiver qualifications? Please revise this sentence for clarity. Definition of Formal Caregivers (Comment 2.3) The authors’ response to the concern about vague eligibility criteria for formal caregivers is not satisfactory. Removing the criterion is not an adequate solution or justification. Instead, the authors should consider incorporating a clearer and stricter definition of “formal caregivers,” such as minimum years of experience, specific care responsibilities, or formal employment status in caregiving services. Sentence Clarity (pg. 12, lines 238–241) The following sentence is clunky and difficult to follow: “This process followed the standard adaptation guidelines provided by WHO (38) upon informing them about the adaptation of the iSupport manual for the specific context of Bangladesh, and international adaptation practices (33,34) to ensure the manual’s suitability for Bangladeshi caregivers.” I suggest restructuring it for clarity. For example: “The adaptation process followed the standard guidelines provided by WHO (38), and the research team informed WHO about the adaptation for the Bangladeshi context. International adaptation practices (33,34) were also followed to ensure the manual’s relevance and suitability for caregivers in Bangladesh.” Data Availability Statement The authors mention that de-identified participant data will be made publicly available as supplementary information. However, it remains unclear where this data will be published- whether as supplementary files alongside a results publication, in a specific data repository, or on an institutional platform. Please clarify the planned location and format for data sharing to meet transparency and open science standards. Conclusion This protocol presents an important study that fills a critical gap in dementia caregiver support research in Bangladesh. If the remaining issues listed above are addressed, particularly those relating to clarity, definitions, and transparency, the manuscript will be significantly strengthened. Reviewer #2: Reviewer comments have been addressed adequately. No further comments to the authors. xxxxxxxxxxxxxx ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Upasana Baruah Reviewer #2: Yes: Mathew Varghese ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Impact of iSupport on improving knowledge on dementia and dementia care among family caregivers to persons with dementia and formal caregivers in Bangladesh: Protocol for a non-randomized feasibility study PONE-D-24-22636R2 Dear Dr. Islam, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Fernanda L. F. Dal Pizzol Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable??> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors described where all data underlying the findings will be made available when the study is complete??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics. You may also provide optional suggestions and comments to authors that they might find helpful in planning their study. Reviewer #1: My previous comments have been satisfactorily addressed and suggestions incorporated. I have no further comments Reviewer #2: Reviewers comments have been addressed adequately. The article has already been reviewed three times. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Dr. Upasana Baruah Reviewer #2: Yes: Mathew Varghese ********** |
| Formally Accepted |
|
PONE-D-24-22636R2 PLOS ONE Dear Dr. Islam, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Fernanda L. F. Dal Pizzol Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .